期刊文献+

Shenxian Shengmai Oral Liquid for treatment of slow arrhythmia: a randomized controlled trial 预览

Shenxian Shengmai Oral Liquid for treatment of slow arrhythmia: a randomized controlled trial
在线阅读 下载PDF
收藏 分享 导出
摘要 缓慢性心律失常是临床上比较常见的疾病,在中老年人群中有着较高的发病率.已经有多项临床研究表明,参仙升脉口服液可以缓解改善缓慢性心律失常患者的临床症状.本试验纳入60名缓慢性心律失常的受试者,按照2:1随机分配到试验组(参仙升脉口服液)和对照组(参仙升脉口服液模拟剂)中.该临床试验是一项先导性试验,比较参仙升脉口服液治疗慢性心律失常的疗效,初步明确参仙升脉口服液对缓慢性心律失常患者的安全性及有效性. Background: Slow arrhythmia, a common clinical condition, has a higher incidence in the elderly population. Shenxian Shengmai Oral Liquid has been shown to improve the symptoms of patients with slow arrhythmia in many clinical studies and systematic reviews. Sixty participants with slow arrhythmia will be randomized to treatment group (Shenxian Shengmai Oral Liquid) and control group (Shenxian Shengmai Oral Liquid Placebo) in a 2:1 ratio. This clinical trial is a pilot study to compare the effects of Shenxian Shengmai Oral Liquid and the control groups; to analyze the effect of Shenxian Shengmai Oral Liquid for slow arrhythmia.
出处 《TMR现代中药》 2018年第2期12-17,共6页 TMR Modern Herbal Medicine
基金 The trial is sponsored by Ten Thousand People Plan (2016) and Natural Science Foundation of China (No.81273935).
关键词 缓慢性心律失常 参仙升脉口服液 临床试验 Slow arrhythmia, Shenxian Shengmai Oral Liquid, Clinical trial
  • 相关文献
投稿分析
职称考试

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈